Intra Cellular Therapies Inc's Comment on Supply Chain
The company sources its active pharmaceutical ingredient (API) and intermediates for lumateperone from third-party manufacturers. It has a supply agreement with Siegfried Evionnaz SA, an affiliate of Siegfried AG, effective January 5, 2023, for the manufacturing and supply of API and intermediates in commercial quantities. This agreement has an initial three-year term, renewable annually, and includes specified purchase prices based on volume. The company has committed to purchasing production campaigns from Siegfried expected to be delivered in 2025. Additionally, the company has a manufacturing services agreement with Lonza Ltd., amended on December 19, 2022, extending the term until December 31, 2028, with minimum annual purchase commitments for 2025 through 2028. Both agreements permit termination under certain conditions, including material breach or insolvency. The company may also procure API and intermediates from other suppliers as needed.
Intra Cellular Therapies Inc's Comment on Supply Chain
The company sources its active pharmaceutical ingredient (API) and intermediates for lumateperone from third-party manufacturers. It has a supply agreement with Siegfried Evionnaz SA, an affiliate of Siegfried AG, effective January 5, 2023, for the manufacturing and supply of API and intermediates in commercial quantities. This agreement has an initial three-year term, renewable annually, and includes specified purchase prices based on volume. The company has committed to purchasing production campaigns from Siegfried expected to be delivered in 2025. Additionally, the company has a manufacturing services agreement with Lonza Ltd., amended on December 19, 2022, extending the term until December 31, 2028, with minimum annual purchase commitments for 2025 through 2028. Both agreements permit termination under certain conditions, including material breach or insolvency. The company may also procure API and intermediates from other suppliers as needed.
Sources:
Intra cellular Therapies Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Intra cellular Therapies Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
